JUDY LIM: Open Payments
NPI 1083667208 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 64 payments from 20 companies in 2025. Trend: 2023 $2,027 · 2024 $1,864 · 2025 $1,583
Food & beverage: $1,551Education: $32
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $368 |
| Lilly USA, LLC | 11 | $316 |
| Novo Nordisk Inc | 7 | $139 |
| GlaxoSmithKline, LLC. | 7 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| PFIZER INC. | 4 | $79 |
| Abbott Laboratories | 3 | $68 |
| Exact Sciences Corporation | 3 | $65 |
| Amgen Inc. | 2 | $43 |
Products named: BREZTRI, MOUNJARO, JARDIANCE, REXULTI, Ozempic, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit.
Industry payments across DE — which companies pay providers there.
